BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 22862156)

  • 1. Induction of respiratory immune responses in the chicken; implications for development of mucosal avian influenza virus vaccines.
    de Geus ED; Rebel JM; Vervelde L
    Vet Q; 2012 Jun; 32(2):75-86. PubMed ID: 22862156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Examination of the effects of virus inactivation methods on the induction of antibody- and cell-mediated immune responses against whole inactivated H9N2 avian influenza virus vaccines in chickens.
    Astill J; Alkie T; Yitbarek A; Taha-Abdelaziz K; Bavananthasivam J; Nagy É; Petrik JJ; Sharif S
    Vaccine; 2018 Jun; 36(27):3908-3916. PubMed ID: 29853199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protection against H7N3 high pathogenicity avian influenza in chickens immunized with a recombinant fowlpox and an inactivated avian influenza vaccines.
    Bertran K; Sá E Silva M; Pantin-Jackwood MJ; Swayne DE
    Vaccine; 2013 Aug; 31(35):3572-6. PubMed ID: 23707445
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and synergy of live-attenuated and inactivated influenza vaccines in young chickens.
    Jang H; Elaish M; Kc M; Abundo MC; Ghorbani A; Ngunjiri JM; Lee CW
    PLoS One; 2018; 13(4):e0195285. PubMed ID: 29624615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging Role of Mucosal Vaccine in Preventing Infection with Avian Influenza A Viruses.
    Wang T; Wei F; Liu J
    Viruses; 2020 Aug; 12(8):. PubMed ID: 32784697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of Immune Responses to an Inactivated Avian Influenza Virus Vaccine Adjuvanted with Nanoparticles Containing CpG ODN.
    Singh SM; Alkie TN; Abdelaziz KT; Hodgins DC; Novy A; Nagy É; Sharif S
    Viral Immunol; 2016 Jun; 29(5):269-75. PubMed ID: 27077969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delivery of an inactivated avian influenza virus vaccine adjuvanted with poly(D,L-lactic-co-glycolic acid) encapsulated CpG ODN induces protective immune responses in chickens.
    Singh SM; Alkie TN; Nagy É; Kulkarni RR; Hodgins DC; Sharif S
    Vaccine; 2016 Sep; 34(40):4807-13. PubMed ID: 27543454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of 3 kinds of Toll-like receptor ligands for inactivated avian H5N1 influenza virus intranasal immunization in chicken.
    Liang J; Fu J; Kang H; Lin J; Yu Q; Yang Q
    Poult Sci; 2013 Oct; 92(10):2651-60. PubMed ID: 24046412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Comparison of Toll-Like Receptor 5 and 21 Ligands as Adjuvants for a Formaldehyde Inactivated H9N2 Avian Influenza Virus Vaccine in Chickens.
    Astill J; Alkie T; Yitbarek A; Taha-Abdelaziz K; Shojadoost B; Petrik JJ; Nagy É; Sharif S
    Viral Immunol; 2018 Nov; 31(9):605-612. PubMed ID: 30222508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Effect of Infectious Bursal Disease Virus-Induced Immunosuppression on Vaccination Against Highly Pathogenic Avian Influenza Virus.
    Spackman E; Stephens CB; Pantin-Jackwood MJ
    Avian Dis; 2018 Mar; 62(1):36-44. PubMed ID: 29620467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conserved peptides enhance immune efficiency of inactive vaccines against emerging avian influenza viruses in chicken.
    Xiao J; Zhang L; Wang Z; Xiang W; Lu P; Zhao Y; Han M; Ma A; Qi P; Wang M; Gao GF; Liu WJ
    Sci China Life Sci; 2017 Dec; 60(12):1340-1347. PubMed ID: 29230639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A lack of antibody formation against inactivated influenza virus after aerosol vaccination in presence or absence of adjuvantia.
    de Geus ED; van Haarlem DA; Poetri ON; de Wit JJ; Vervelde L
    Vet Immunol Immunopathol; 2011 Sep; 143(1-2):143-7. PubMed ID: 21683456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective Efficacy of an H5N1 Inactivated Vaccine Against Challenge with Lethal H5N1, H5N2, H5N6, and H5N8 Influenza Viruses in Chickens.
    Zeng X; Chen P; Liu L; Deng G; Li Y; Shi J; Kong H; Feng H; Bai J; Li X; Shi W; Tian G; Chen H
    Avian Dis; 2016 May; 60(1 Suppl):253-5. PubMed ID: 27309064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bursopentine as a novel immunoadjuvant enhances both humoral and cell-mediated immune responses to inactivated H9N2 Avian Influenza virus in chickens.
    Li D; Xue M; Wang C; Wang J; Chen P
    Clin Vaccine Immunol; 2011 Sep; 18(9):1497-502. PubMed ID: 21795462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Avian influenza virus vaccines containing Toll-like receptors 2 and 5 ligand adjuvants promote protective immune responses in chickens.
    St Paul M; Brisbin JT; Barjesteh N; Villaneueva AI; Parvizi P; Read LR; Nagy E; Sharif S
    Viral Immunol; 2014 May; 27(4):160-6. PubMed ID: 24797722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Efficacious Vaccines Against Contemporary North American H7 Avian Influenza Viruses.
    Spackman E; Pantin-Jackwood MJ; Sitaras I; Stephens CB; Suarez DL
    Avian Dis; 2021 Mar; 65(1):113-121. PubMed ID: 34339130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and immunological evaluation of inactivated avian influenza virus vaccine encapsulated in chitosan nanoparticles.
    Mohamed SH; Arafa AS; Mady WH; Fahmy HA; Omer LM; Morsi RE
    Biologicals; 2018 Jan; 51():46-53. PubMed ID: 29126666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative Effectiveness of Two Oil Adjuvant-Inactivated Avian Influenza H9N2 Vaccines.
    Kilany WH; Bazid AH; Ali A; El-Deeb AH; El-Abideen MA; Sayed ME; El-Kady MF
    Avian Dis; 2016 May; 60(1 Suppl):226-31. PubMed ID: 27309059
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of different CpG oligodeoxynucleotides with inactivated avian H5N1 influenza virus on mucosal immunity of chickens.
    Fu J; Liang J; Kang H; Lin J; Yu Q; Yang Q
    Poult Sci; 2013 Nov; 92(11):2866-75. PubMed ID: 24135589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody titer has positive predictive value for vaccine protection against challenge with natural antigenic-drift variants of H5N1 high-pathogenicity avian influenza viruses from Indonesia.
    Swayne DE; Suarez DL; Spackman E; Jadhao S; Dauphin G; Kim-Torchetti M; McGrane J; Weaver J; Daniels P; Wong F; Selleck P; Wiyono A; Indriani R; Yupiana Y; Sawitri Siregar E; Prajitno T; Smith D; Fouchier R
    J Virol; 2015 Apr; 89(7):3746-62. PubMed ID: 25609805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.